Healthcare Sales & Marketing Network News: ISA247

Searching News Database: ISA247

HSMN NewsFeed - 10 Oct 2007
Isotechnika Inc. appoints two new senior company officers
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2007
Isotechnika Inc. announces senior management changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 31 Jul 2007
EMEA Committee for Orphan Medicinal Products Recommends Orphan Medicinal Product Designation for Lux Biosciences' LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 15 Jan 2007
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 28 Nov 2006
Lux Biosciences Receives FDA Clearance for LX211 IND
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 4 Oct 2006
Isotechnika receives No Objection Letter from Health Canada for second Phase III psoriasis clinical trial
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 May 2006
Lux Biosciences Raises $36 Million in Series A Financing and Signs Agreement for Advanced Clinical Stage Product
Biopharmaceuticals Venture Capital Licensing

HSMN NewsFeed - 25 May 2006
Isotechnika signs agreement granting Lux Biosciences Worldwide Ophthalmic rights to ISA247
Biopharmaceuticals Licensing

Return to NewsFeed

Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 12 additional stories matching:
ISA247
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.